Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.

Shailubhai K, Dheer S, Picker D, Kaur G, Sausville EA, Jacob GS.

J Exp Ther Oncol. 2004 Dec;4(4):267-79.

PMID:
15844657
2.

Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.

Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, Ge R.

J Biol Chem. 2005 Jul 29;280(30):27935-48. Epub 2005 May 27.

3.

Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.

Yi EY, Jeong EJ, Song HS, Lee MS, Kang DW, Joo JH, Kwon HS, Lee SH, Park SK, Chung SG, Cho EH, Kim YJ.

Int J Oncol. 2004 Aug;25(2):365-72.

PMID:
15254733
5.

A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis.

Hamma-Kourbali Y, Di Benedetto M, Ledoux D, Oudar O, Leroux Y, Lecouvey M, Kraemer M.

Biochem Biophys Res Commun. 2003 Oct 24;310(3):816-23.

PMID:
14550277
6.

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H.

Oncogene. 2002 Mar 27;21(13):2000-8.

7.

[6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo.

Kim EC, Min JK, Kim TY, Lee SJ, Yang HO, Han S, Kim YM, Kwon YG.

Biochem Biophys Res Commun. 2005 Sep 23;335(2):300-8.

PMID:
16081047
8.

Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.

Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E.

Mol Cancer Ther. 2005 Nov;4(11):1717-28.

9.

Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.

Awasthi N, Schwarz MA, Verma V, Cappiello C, Schwarz RE.

Lab Invest. 2009 Jan;89(1):38-46. doi: 10.1038/labinvest.2008.106. Epub 2008 Nov 10.

10.

Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.

Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T.

Biochem Pharmacol. 2008 Aug 1;76(3):330-9. doi: 10.1016/j.bcp.2008.05.017. Epub 2008 May 28.

PMID:
18599020
11.

Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.

Wang M, Zhang L, Han X, Yang J, Qian J, Hong S, Samaniego F, Romaguera J, Yi Q.

Blood. 2007 Jun 15;109(12):5455-62. Epub 2007 Feb 22.

12.

Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.

Jeon JW, Song HS, Moon EJ, Park SY, Son MJ, Jung SY, Kim JT, Nam DH, Choi-Miura NH, Kim KW, Kim YJ.

Int J Oncol. 2006 Jul;29(1):209-15.

PMID:
16773202
13.

Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.

Kimura Y, Sumiyoshi M, Baba K.

Cancer Sci. 2008 Oct;99(10):2083-96. doi: 10.1111/j.1349-7006.2008.00948.x.

14.

Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.

Yoon WH, Jung YJ, Kim TD, Li G, Park BJ, Kim JY, Lee YC, Kim JM, Park JI, Park HD, No ZS, Lim K, Hwang BD, Kim YS.

Clin Cancer Res. 2004 Jul 1;10(13):4517-26.

15.

Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists.

Soriano JV, Liu N, Gao Y, Yao ZJ, Ishibashi T, Underhill C, Burke TR Jr, Bottaro DP.

Mol Cancer Ther. 2004 Oct;3(10):1289-99.

16.

In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.

Chintalapati M, Truax R, Stout R, Portier R, Losso JN.

J Agric Food Chem. 2009 Jun 24;57(12):5201-10. doi: 10.1021/jf803818y.

PMID:
19476359
17.

Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.

Hseu YC, Wu CR, Chang HW, Kumar KJ, Lin MK, Chen CS, Cho HJ, Huang CY, Huang CY, Lee HZ, Hsieh WT, Chung JG, Wang HM, Yang HL.

J Ethnopharmacol. 2011 Jun 1;135(3):762-71. doi: 10.1016/j.jep.2011.04.016. Epub 2011 Apr 14.

PMID:
21515352
18.

Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.

Kim SA, Lee HJ, Ahn KS, Lee HJ, Lee EO, Ahn KS, Choi SH, Jung SJ, Kim JY, Baek N, Kim SH.

Biol Pharm Bull. 2009 Jul;32(7):1142-7.

20.

Supplemental Content

Support Center